Objective: To investigate the effect of subspecialty practice and experience on the relationship between annual volume and inpatient mortality after hepatic resection. Background: The impact of annual surgical volume on postoperative outcomes has been extensively examined. However, the impact of cumulative surgeon experience and specialty training on this relationship warrants investigation. Methods: The New York Statewide Planning and Research Cooperative System inpatient database was queried for patients' !18 years who underwent wedge hepatectomy or lobectomy from 2000 to 2014. Primary exposures included annual surgeon volume, surgeon experience (early vs late career), and surgical specialization-categorized as general surgery (GS), surgical oncology (SO), and transplant (TS). Primary endpoint was inpatient mortality. Hierarchical logistic regression was performed accounting for correlation at the level of the surgeon and the hospital, and adjusting for patient demographics, comorbidities, presence of cirrhosis, and annual surgical hospital volume. Results: A total of 13,467 cases were analyzed. Overall inpatient mortality was 2.35%. On unadjusted analysis, late career surgeons had a mortality rate of 2.62% versus 1.97% for early career surgeons. GS had a mortality rate of 2.98% compared with 1.68% for SO and 2.67% for TS. Once risk-adjusted, annual volume was associated with reduced mortality only among earlycareer surgeons (odds ratio 0.82, P ¼ 0.001) and general surgeons (odds ratio 0.65, P ¼ 0.002). No volume effect was seen among late-career or specialtytrained surgeons. Conclusions: Annual volume alone likely contributes only a partial assessment of the volume-outcome relationship. In patients undergoing hepatic resection, increased annual volume did not confer a mortality benefit on subspecialty surgeons or late career surgeons.
A nnual surgeon volume has been identified as a major predictor of mortality after major operations, including hepatectomy. 1 Although studies have demonstrated a survival benefit for patients undergoing major resection at high-volume hospitals by high-volume surgeons, [2] [3] [4] debate has arisen on the potential unintended consequences of restricting cases above individual surgeon volume thresholds and whether annual volume alone is the best marker to allow for optimization of patient outcomes. [5] [6] [7] [8] Utilizing annual surgeon volume offers an easy to measure proxy for quality 9 ; however, annual surgeon volume alone may not appropriately capture the underlying phenomena that differentiate high performing and low performing surgeons. One can imagine that beyond volume, there are other measures of a surgeon's expertise or proficiency, which can contribute beneficially to patient outcomes. Supporting such a hypothesis, recent work has demonstrated that other factors, such as surgeon procedure specialization, can be predictive of mortality independent of annual surgeon volume. 10 In addition to specialization, experience over time, a cumulative volume effect, may have a role in predicting outcomes after surgery. 11, 12 The goal of our study was to investigate the effect of cumulative experience over an entire career, and subspecialty practice, on the relationship between volume and inpatient mortality after hepatic resection.
METHODS

Patient Database
The New York (NY) Statewide Planning and Research Cooperative System (SPARCS) inpatient database was utilized to capture patients undergoing surgery from 2000 to 2014. SPARCS is a database for the state of NY that captures all patients and payers and collects information on patients, treatments, and providers for every emergency department admission, inpatient admission/hospital discharge, outpatient visit, and ambulatory surgery. SPARCS also contains a unique physician identifier that allows for identification of each patient's physicians for an episode of care. Unique physician identifiers in SPARCS correspond to identifiers maintained in the New York Physician License database, which contains information on physician identity, including year of medical school graduation.
Study Population
All patients over the age of 18 years who underwent wedge hepatectomy or lobectomy were identified and included using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD9-CM) procedure codes (50. 3, 50.22) . Patients who underwent trauma or recipient (ie, transplant) hepatectomy were excluded. Each procedure was attributed to an individual surgeon by a unique surgeon identifier within the dataset.
Main Exposures
Our main exposures were individual surgeon annual volume, surgeon experience, and surgeon specialty. 
Surgeon Identification by Career Stage
Surgeon status as ''early career'' versus ''late career'' was determined by calculating years since medical school graduation. Surgeons with a fewer than 20 years out from graduation were labeled as early career and those 20 years or greater from graduation were labeled as late career. Twenty years was selected as the cut-off for an early career surgeon under the assumption that surgical residency lasts 5 to 7 years and fellowship training (if applicable) lasts 1 to 2 years. Thus, a 20-year cut-off could be reasonably expected to capture the first 10 to 12 years of a surgeon's independent practice.
Surgeon Identification by Specialty
Liver transplant centers were identified using the Scientific Registry of Transplant Recipients (SRTR). Institutional websites of liver transplant centers were mined for liver transplant faculty affiliation and linked to the New York Physicians License database to allow linking of transplant surgeon (TS) status to SPARCS data. The Society of Surgical Oncology (SSO) physician database was utilized to identify surgeons with a SSO affiliation and linked to the New York Physicians License database to allow for linking of SSO affiliation to SPARCS data. These surgeons are subsequently referred to as surgical oncologists (SO). SO status was cross-referenced against institutional websites for verification of surgeon specialty. All other surgeons were categorized as general surgeons (GS).
Outcome Measures
The primary outcome measure was inpatient mortality (ie, death on index admission for hepatectomy). Death was determined based on a mortality variable coded into the SPARCS dataset.
Statistical Analysis
Baseline demographic characteristics were analyzed. Unadjusted analysis was performed to compare patients who were operated on by early versus late career surgeons, and those operated on by GS versus SO versus TS.
Several multilevel logistic regressions were performed to investigate the volume-specialty and volume-experience relationship. We accounted for clustering of surgeon and hospital by using a nested multilevel model. We adjusted for age, year of operation, race/ ethnicity, payer status, Charlson Comorbidity Index (CCI), need for biliary-enteric reconstruction, presence of hepatic malignancy (primary vs secondary tumor), hepatic necrosis, and presence of one or more complications (eg, postoperative shock, hemorrhage, cardiac complication, wound complication, postoperative infection, respiratory/ventilator-associated complications, anastomotic leak, and urinary complication), and annual hospital volume. Annual individual surgeon volume was initially examined as a continuous variable.
Subset analysis was performed to assess for the role of annual surgeon volume on mortality in early career and late career surgeons, as well as in general, oncologic, and transplant surgeons. Additionally, patients were divided into quartiles based on their surgeon's annual volume to enable visualization of the relationship of experience and specialization across sub-groups of annual volume. Adjusted mortality rates were calculated from odds ratios using the marginal standardization form of predictive margins. 13 Significance level was set at alpha ¼ 0.05.
Statistical analysis was performed using STATA 14/IC (StataCorp, College Station, TX).
RESULTS
A total of 13,467 hepatectomies were performed from 2000 to 2014 in the state of NY with a crude inpatient mortality rate of 2.35%. The majority of patients were Caucasian, and half were females. Patients of TS tended to be racial minorities, had a diagnosis of cirrhosis, and were more likely to undergo lobectomy than wedge hepatectomy, compared to patients of GS and SO (Table 1) .
A total of 909 individual surgeons were identified. The majority of surgeons were GS (n ¼ 850, 93.5%), of which most were late career ( Table 2 ). Late career surgeons were more likely to perform a hepatic lobectomy than early career surgeons (Table 1) . One third of patients were operated on by GS, one quarter by TS, and the remaining patients by SO.
On unadjusted analysis, late career surgeons had a mortality rate of 2.62% versus 1.97% for early career surgeons (P < 0.014). GS had a mortality rate of 2.98% compared with 1.68% for SO and 2.67% for TS. After risk adjustment, patient age greater than 60 years, Medicare payer status, primary liver tumor, need for biliary-enteric reconstruction, and lobectomy were significant predictors of inpatient mortality (Table 3 , all P < 0.02). Early career status and surgeon specialization were not significant predictors of mortality. In the overall patient cohort, annual surgeon volume was not a significant predictor for inpatient mortality (odds ratio, OR, 0.94, 95% confidence interval, CI, 0.85-1.05, P ¼ 0.259).
On subset analysis, annual surgeon volume was a significant predictor of inpatient mortality for early career surgeons and GS. Adjusted mortality rate by annual volume quartiles demonstrates a significantly higher mortality rate for early career surgeons in the bottom volume quartile (P ¼ 0.008) (Fig. 1 ). In addition, adjusted mortality rate of GS was significantly higher in the bottom volume quartile (P ¼ 0.04) (Fig. 2) . No significant differences in adjusted mortality rate were seen across quartiles for late career surgeons, SO, or TS.
DISCUSSION
The results of this study demonstrate that annual surgical volume is associated with lower inpatient mortality after hepatic resection performed by early career surgeons and general surgeons. No significant effect of annual volume was seen on predicted mortality for late career surgeons or surgeons who specialize in liver surgery (ie, SO and TS). These findings suggest that annual surgical volume alone may not be predictive of decreased inpatient mortality for all surgeons. Our work suggests that the need for surgeons to maintain high annual volume may be more relevant for some groups of surgeons and not others. Accrual of cumulative experience (as reflected by years since medical school graduation) or specialization in liver surgery may obviate the need for surgeons to maintain high annual volume to optimize their mortality rate after hepatectomy.
Cumulative experience is a difficult metric to capture as no central database captures longitudinal data of all surgeons and their patient outcomes across states; thus, alternative methods have been utilized to attempt to determine whether cumulative experience is predictive of operative outcomes. For example, surgeon age has been investigated as a surrogate marker with mixed findings depending on case complexity.
14 Using a different technique for assessment of surgeon experience, Yeo et al 12 found, similar to our results, that cumulative experience matters. The authors calculated case volumes over a 5-year period to estimate cumulative experience and found cumulative experience, in conjunction with annual volume, to be a significant predictor of decreased complications after rectal surgery. We utilized years since graduation from medical school as a surrogate marker for cumulative experience and found significant predictive effect of annual volume in early-but not late-career surgeons.
The latter suggests that experienced surgeons may not need to maintain high annual volume to optimize postoperative mortality rates after hepatectomy.
Prior research has suggested that surgeon specialization is more likely to yield improved operative outcomes, though the effect varies by type of operation. 15 Sahni et al 10 demonstrated in a Medicare population that surgeon specialization was a predictor of operative mortality independent of annual volume for coronary artery bypass grafting, valve replacement, carotid endarterectomy, abdominal aortic aneurysm repair, cystectomy, and lung resection. Their work further suggested that surgeon specialization may account for part of the volume-outcome relationship in operative mortality. Through a different approach, our findings suggest a similar phenomenon in hepatectomy. For surgeons who specialize in liver surgery, annual volume thresholds may not be the best mechanism to optimize postoperative mortality rates after hepatectomy.
This study has several limitations-many of which arise from the utilization of a single state database. However, many of the limitations of using this single state database may be offset by its relative strengths. Although utilization of a single state database raises concern about the generalizability of the results, SPARCS is one of the only all-payer databases that allows for identification of individual surgeons over a longitudinal period. Furthermore, it is the only all-payer database that allows for additional data enhancement such as identification of surgeons' subspecialty practice. Use of a single state database does not allow for complete data capture of specific cumulative case volume that a surgeon performs over their career, unless a surgeon spends their entire career in that single state. Thus, years since medical school graduation are used as a surrogate marker for cumulative experience. Alternative methods, such as capturing cumulative case volume over a predetermined 5-year time frame, may not be representative of the cumulative case volume of an entire career. 11, 12 Use of institutional and society affiliation may not capture fellowship training but is more likely to include surgical subspecialists who may not have been fellowship eligible at the start of their career but whose practices are predominantly hepatobiliary in nature (ie, ''grandfathered'' into a specialty).
Despite these limitations, our findings have policy implications related to work surrounding the volume-outcome relationship and can help influence the practice of surgeons. Our work suggests that implementing surgeon annual volume cut-offs for hepatectomy may not result in improvements in inpatient mortality rate for experienced or subspecialist surgeons. Furthermore, low-volume early career FIGURE 2. Risk-adjusted mortality rate by surgeon specialty and quartile of annual volume. Quartiles are compared within each specialty. Ã P < 0.05.
surgeons and general surgeons may consider partnering with more experienced surgeons or subspecialists when performing hepatectomy to allow for the greatest benefit in operative risk reduction. Such mentoring relationships likely already informally exist at many institutions, and studies of formal mentoring programs suggest it is an effective strategy to optimize outcomes. 16 Similarly, partnership between hospitals that were high and low volume in hepatobiliary surgery has resulted in improvements to postoperative outcomes 17 ; however, such partnerships may come across regulatory obstacles depending on the local political and economic environment. Therefore, additional work should evaluate the effectiveness of pairing low-volume early career or general surgeons with experienced mentors to determine what types of mentoring partnerships are most beneficial. Finally, future research should assess whether similar relationships between experience and outcomes exist in other types of operations.
CONCLUSIONS
Although annual individual surgeon volume matters, annual volume alone likely gives a partial picture of the volume-outcome relationship. In hepatectomy, increased annual volume does not confer a mortality benefit on late career or subspecialty surgeons; thus, experienced surgeons may not have to maintain high annual volume of hepatectomy to optimize inpatient mortality rate. Additional research should further investigate other characteristics that may modify the volume-outcome relationship and whether similar phenomena are noted in other major operations.
DISCUSSANTS Dr William Chapman (St. Louis, MO):
Drs Pappas, Drebin, Weigel, and members and guests. I appreciate the opportunity to discuss this important article assessing the role of surgical outcomes associated with hepatectomy presented by Drs Hashimoto, Vagefi, and colleagues from the Massachusetts General Hospital.
In this report, as we have heard, the authors utilized the New York Statewide Planning and Research Cooperative Inpatient Database System to assess outcomes after either wedge hepatectomy or lobectomy from 2000 through 2014. The data were risk adjusted, and the authors investigated the timing within the surgical career, that is early versus categorized as late career, and surgical specialty background and concluded that surgical volume alone, when potentially playing a partial role, does not tell the whole story of patients undergoing hepatectomy.
Specifically, the authors found that surgical case volume did appear to have an association with reduced mortality, but only for those surgeons early in their careers as well as for nonspecialtytrained general surgeons. No volume effect was seen among late career or specialty trained surgeons.
I commend the authors on investigating the subtleties associated with surgical outcomes and demonstrating the volume alone, whereas a surrogate for improved outcomes is much more complicated, especially in complex areas of surgery such as hepatic resection. In the current era where advanced subspecialty training has essentially become the norm in complex areas of general surgery, this has to play a role in affecting outcomes. The authors demonstrate that background and training may play an important role along with volume, and this seems to make sense in assessing results.
I have several questions for the authors. First, could you speak a little more about your classification regarding subspecialty training? As I understand it, the transplant association was taken from surgeons who performed transplant surgery at specialized approved centers using data provided by the SRTR. This likely seems accurate and would confer transplant training. On the other hand, a designation as a surgical oncologist seems to have been made for those who are just members within the Society of Surgical Oncology. How does membership in the SSO confer the training level, and especially HPB training with regards to hepatectomy? I would also speculate that there could be a specific number of surgeons who had specialized HPB training who are not members of the SSO. What about surgeons who trained at HPB-specific sites? Did you assess membership in the AHPBA, for example? Even within those trained for transplant surgery, the level of HPB training may have a high degree of variability. These factors would give me pause regarding confidence as far as specialty training is concerned for this assessment.
Second, would you comment on the designation of lobectomy or major hepatectomy versus wedge resection? Does lobectomy mean hemihepatectomy or could lobectomy mean left lateral segment removal? These are differing in complexity as are all major hepatic resections. So the nature of the actual liver resection, I think, could be in question.
Third, could you comment on the results for the late career compared with the early career surgeons? Interestingly, it appeared to me that the late-career surgeons actually had a higher mortality rate compared with early-career surgeons.
Does this mean that late-career surgeons lose their skill set or judgment, or have worse outcomes in early career surgeons? Or perhaps this could be that this group will take on case complexity that's not captured in your risk adjustment that earlier career surgeons would tend to avoid.
Finally, what should we do with surgical volume and specialty training results? This is really the elephant in the room that creates angst for practitioners in the field.
Should only those surgeons with certain HPB specialty training or demonstrated volume of cases be performing such cases, and who should make such decisions? The hospital? Or should there be state regulations and, in this case, the state of New York, or should some other measure be used? I congratulate the authors as an excellent article demonstrating the volume of hepatectomy cases is important in considering outcomes, but this is only part of the story, and other important variables need to be considered in assessing results. Thank you.
Dr Parsia A. Vagefi (Boston, MA):
Thank you, Dr Chapman, for your comments. And thank you, Daniel Hashimoto, one of our excellent residents, for putting together the research and presenting it so nicely.
In regards to your question on subspecialty training, I agree with you. The affiliation with SSO was used as a proxy for training. And I agree; it is not an exact marker of training in hepatic surgery. We did not cross-link to the AHPBA data set, which is a limitation and something to consider for future application. However, to ensure accuracy of our dataset, we looked at non-SSO surgeons and non transplant surgeons who were doing more than 5 hepatectomies a year, and we did investigate those individuals on an individual basis to make sure they were categorized in the appropriate category as being general surgeon, surgical oncologist, or transplant surgeon.
I agree that training in hepatic surgery can vary depending on the fellowship being pursued, whether it's a transplant fellowship, surgical oncology fellowship, or an HPB fellowship. And this has been shown by Rebecca Minter and colleagues in a 2015 HPB article. Not only can training vary depending on the fellowship type pursued but also on where you do your fellowship. For instance different transplant fellowships have different levels of hepatobiliary training.
There was a ASTS, SSO, AHPBA Consensus Conference in 2014 to help try to define some of these areas with regards to fellowship training Continued discussion in this area is needed as we try to standardize the requirements for training in hepatic surgery across the board for the various types of fellowships.
In regards to your question on lobectomy versus wedge resection, again, this was based on ICD 9 codes. The SPARCS database is excellent for certain aspects of transparency. However, it does have its limitations, and one of which is not being able to view individual operative reports, thus limiting our ability to see exactly what was done in the operating room. More granular data in this area is needed.
In regards to your question in late career versus early career surgeons, although on unadjusted analysis you are correct that there was a significant difference in mortality with late career surgeons having a higher mortality than early career surgeons. However, once this was risk adjusted, this difference in mortality was not observed. What we did show was that despite the same median annual volume between late and early career surgeons, volume was not a significant predictor of inpatient mortality for late career surgeons. It was only such for early career surgeons.
Finally, and perhaps most importantly, how do we incorporate these results? And who should be doing these cases? Our ultimate goal is to optimize patient outcomes. And this should not come at the expense of limiting patients' access to care through regionalization nor by excluding certain subsets of dedicated surgeons. But what we do show is that early career surgeons, or those without specialty training, are volume dependent when it comes to hepatic surgery. Thus, we propose that for these volume dependent groups pursuing hepatic surgery, perhaps consideration of a partnership or mentoring with late career or specialty trained surgeons is warranted. Obviously, more research in this area is needed.
In terms of your last comment, whatever the experience criteria that we set out to use, I think we would all agree that surgeons should be at the table in having these discussions, and this should not be relegated to the state to decide.
Dr Jean Emond (New York, NY):
Thank you for the great work and congratulations to Dr Hashimoto for a beautiful job presenting.
If I'm not mistaken, the first articles linking hepatectomy volume to outcomes came out 2 decades ago, and similar articles were done for pancreatic surgery and others. To my knowledge, there hasn't been a lot of progress in terms of public policy with restrictions of patients to specialty centers.
On the other hand, looking at your overall results it seems that, for the most part, surgeons are pretty good figuring out what operations they should be doing and not be doing because the overall mortality was quite low even for the small-volume surgeons.
Did you consider looking at the subset of very large volume centers that do 50 or even 100 cases a year? Is that a more suitable arena in which to look for major liver surgery being done? And to pursue Dr Chapman's point about the risk adjustment, it's very likely that what you've been able to do with this data set does not adequately capture either complexity or comorbidities of the cases that are being taken on, which might account for the higher mortality in some of the more experienced surgical teams. Thanks again for your work.
Dr Parsia A. Vagefi (Boston, MA):
You bring up an excellent point. Clearly in the state of New York there are a few large volume centers, one of which in fact accounts for 30% of the hepatic resection volume. We adjusted for hospital volume, but there are other factors involved within a hospital that can contribute to overall experience, such as nursing, advanced endoscopy, ICU level of care, to name a few factors that we could not capture in this data set.
This data set allowed us to focus on certain patient factors, and surgeon specific data in regard to specialization and training. But we agree that the missing pieces that we need to further investigate are the additional hospital factors. Some of the effect of surgeon volume and hospital volume will be overlapping, and we adjusted for this. A high volume surgeon is likely going to be in a high volume hospital, but despite this overlap we need to tease out those nonvolume-based components that are part of a hospital system that perhaps could be extrapolated to the other centers that are low volume.
Dr Henry Pitt (Philadelphia, PA):
I would like to applaud the authors for analyzing the role of surgeon experience and specialization on mortality after hepatectomy. However, I have concerns regarding the limitations of the New York State database to fully examine these and related questions.
One issue is the time period studied. The HPB fellowships in the US only started 10 to 12 years ago so very a few New York surgeons have been ''HPB'' trained.
Another issue is that current hepatic surgery has multiple nuisances not captured in the SPARCS database. For example, data on additional preoperative and intraoperative procedures like portal vein embolization or tumor ablation, which influence outcomes, are not available. Also, overall and hepatectomy-specific morbidity were not studied but are very important outcomes.
Thirdly, the number of cases analyzed was only 13,000 over 15 years. In comparison, in the ACS-NSQIP HPB Collaborative dataset for 2014 to 16, we are capturing more than 3000 hepatectomies per year. The NSQIP data are national, very nuisanced, and highly risk-adjusted and provide data on morbidity and mortality. Thus, I would recommend that you consider utilizing the NSQIP hepatectomy database for future analyses.
Dr Parsia A. Vagefi (Boston, MA):
Thank you for your comments. We agree that the ACS NSQIP HPB collaborative database is a robust data set and we hope to use it in the near future. However, the advantage of the SPARCS dataset was being able to identify and track individual physicians and thus determine their level of training and expertise.
Dr Prabhakar Baliga (Charleston, SC):
Congratulations on a great paper. In the transplant world, our results are publicly reported, and for a two-point decrease in your patient or graft survival programs are flagged. In return, several studies have shown a significant decrease in access to care, almost a 30% decrease in the transplant programs, has been flagged.
So my concern here is that what is statistically significant and what is clinically relevant when you're looking at small differences in mortality which could then significantly impact access to care for patients? Perhaps it may not be relevant to New York, but I think particularly in other states, which do not have Medicaid expansion, and so on, this may have a much larger negative impact on patients receiving care. Thank you.
Dr Parsia A. Vagefi (Boston, MA):
That is a good point. I think our ultimate goal is to decrease the inpatient mortality as much as possible, and thus even a small decrease in percent mortality can end up making a difference for the individual patient. Furthermore, there remains the potential to investigate the effect of cumulative experience on other disease processes, which may have higher rates of mortality.
Dr Lawrence Way (Corte Madera, CA):
Could the findings be better understood by studying the learning curves of the surgeon? Perhaps some of the surgeons are on the steep part of the learning curve while others have reached a plateau.
Thank you for your comment, Dr Way. That goes along to what Dr Chapman was alluding to as well. That's the next step in the investigation of the data set, is to look at the learning curve and see if there is a threshold.
Dr John Cameron (Baltimore, MD):
I enjoyed this article very much. It's interesting, one of your senior authors, Keith Lillemoe, knows this certainly and I do; for Whipples, the mortality correlates more with the institution than with the individual surgeon. And in high-volume institutions, both highvolume surgeons and low-volume surgeons have the same low mortality. Now, can you cluster your surgeons into institutions so that you can determine whether the low-volume surgeons with hepatectomies have the same low mortality as the high-volume surgeons in the high-volume institution?
Thank you Dr Cameron for your comments. Although our multi-level model accounted for nesting of surgeons within hospitals, we did not analyze this specifically by individual hospital. However, if you look at it by specialty training, transplant surgeons or surgical oncologists across different volume quartiles had no difference in mortality. We would suspect that these specialty-trained surgeons are at higher-volume institutions.
Dr John Cameron (Baltimore, MD):
The real problem is that the mortality is too low in your study. You should just use lobectomy and not wedge resections and other procedures, because the mortality of 2% is too low to show any significant differences between most individuals or institutions.
Dr Parsia A. Vagefi (Boston, MA):
That is a valid point. The inpatient mortality rate for lobectomy was 3.9%, whereas it was 1.8% for patients undergoing wedge resection.
